HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G names four presidents

This article was originally published in The Rose Sheet

Executive Summary

VPs Marc Pritchard and Paolo de Cesare promoted to president of their respective divisions in recognition of their strong leadership contribution, P&G announces July 25. Pritchard oversees global cosmetics and personal care, while de Cesare directs global prestige beauty and skin care. Two additional execs also were promoted to president from current VP roles - Michael Kehoe, who oversees global oral care, and Martin Riant, who heads global feminine care. Presidential posts are new positions that will be effective Sept. 1. Pritchard and de Cesare were appointed to their current roles last year (1"The Rose Sheet" April 29, 2002, In Brief)...

You may also be interested in...



P&G management changes

Cosmetics VP Marc Pritchard promoted to VP-global cosmetics and personal care, assuming responsibility for global personal cleansing, deodorants in addition to existing responsibility for Cover Girl and Max Factor, Procter & Gamble announces. Appointment is effective July 1. Paolo de Cesare, currently VP-Northeast Asia skin care and cosmetics, appointed VP-global prestige beauty and skin care, taking on responsibility for P&G's global fine fragrances and mass skin care brands, including Olay, while continuing to oversee SKII brand. Execs will report to President-Global Personal Beauty Care Susan Arnold, who will assume added leadership of global feminine care business...

Warning Letter Roundup & Recap – 21 January 2020

A maker of low-level LED light-therapy devices was cited by the US FDA for premarket, quality systems and Medical Device Reporting violations. It's just one of two device-related warning letters released by the agency this week.

Compliance Corner: The 10 Best – And 10 Worst – Things You Can Do When FDA Inspects Your Firm (Part 6)

A panel of longtime industry experts offer manufacturers a list of things they should and shouldn’t do when an investigator from the US agency knocks on their facility door. In this sixth installment of a 10-part series, experts David Elder and John McKay address communication between the front room – where investigators do the majority of their work – and the back room, used by company workers to fulfill investigator requests for documents, records and other information.

UsernamePublicRestriction

Register

RS011412

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel